ONVO Stock Performance, Insider Transaction and News

ONVO - Organovo Holdings, Inc.

Market Cap	14.38M	P/E	-	EPS this Y	12.10%	Ern Qtrly Grth	-
Income	-19.09M	Forward P/E	-7.86	EPS next Y	21.30%	50D Avg Chg	-6.00%
Sales	242k	PEG	-	EPS past 5Y	-	200D Avg Chg	-10.00%
Dividend	N/A	Price/Book	0.94	EPS next 5Y	-	52W High Chg	-56.00%
Recommedations	3.00	Quick Ratio	3.13	Shares Outstanding	11.39M	52W Low Chg	20.00%
Insider Own	1.91%	ROA	-72.77%	Shares Float	9.87M	Beta	0.90
Inst Own	7.95%	ROE	-134.07%	Shares Shorted/Prior	149.71K/135.37K	Price	1.65
Gross Margin	-	Profit Margin	-	Avg. Volume	23,632	Target Price	8.55
Oper. Margin	-73,600.00%	Earnings Date	Jul 11	Volume	15,506	Change	1.85%

Healthcare | Biotechnology | United States

About Organovo Holdings, Inc.

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Organovo Holdings, Inc. News

05/08/24	Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
05/01/24	ONVO Announces Very Positive Phase 2 Results
04/15/24	Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
03/28/24	Top 15 3D Printing Companies in the US
02/10/24	Organovo Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
07:15 AM	ONVO Continues Progress
01/25/24	Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
08:05 AM	Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
12/06/23	Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
11/13/23	CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan
11/13/23	OVNO Continues Developing Breakthrough Treatments
11/11/23	Organovo Holdings Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.38 loss in 2Q 2023)
11/08/23	Organovo Highlights FXR314 Combination Therapy Potential and Plan
10/10/23	ONVO: A Company With Great Technology to Impact Health Care
09/08/23	Organovo to Participate in the H.C. Wainwright Global Investment Conference
08/25/23	Is Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
08/23/23	Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
07/12/23	Net Asset Value(s)
05/25/23	Cathie Wood is Selling These 12 Stocks in 2023

ONVO Chatroom

Stock_Titan Posted - 7 hours ago

$ONVO Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering https://www.stocktitan.net/news/ONVO/organovo-holdings-inc-announces-pricing-of-5-25-million-public-7fk3tsusnen1.html

speedcomander Posted - 18 hours ago

$ONVO

Catdaddy770 Posted - 1 day ago

$ONVO is this still alive lol This was my first real trade and I made like $10k on a run to $12 when I was like 20. Thought the company ended up being a fraud

OkIGotIt Posted - 1 day ago

$ONVO making 8% up after hour! Grabbed some alerady! Bullish!! Let's GO!

Abjo Posted - 1 day ago

$ONVO Grabbed some before close

OkIGotIt Posted - 1 day ago

$ONVO 7% up pre-market!

OkIGotIt Posted - 2 days ago

$ONVO The float is SO tiny and price went down $1 giving buyers waiting on sidelines to jump in to purchase on bulk. Last time it went down $1, the next day it hit $1.23. Loading tons now! Bullish!

TacoMojo Posted - 3 days ago

$ONVO I don't see much here. I've been a shareholder for a long time and figured I'd wait it out. Problem is as I see it, they have less than a year's worth of cash burn, even if they do a dilutive offering it will place them below the $1/PPS - way way below. If they do a reverse to keep listed then the ability to do a dilutive offering then tanks all common (I mean all common are pretty much tanked already). So the only possibility I see if a bulk cash grant for development or an asset/proprietary sale. The latter is no good for ONVO, the former - well dunno who's gonna step up. I really liked the bio-printing technology and now they have gone into oral drug therapeutics. It' s a segue that while evident is also opaque - to me. I'm not selling - however I'm not convinced there's a buy upside given the overall condition. I suppose I could be missing something but it seems they need five years of cash and they only have one.

intratio Posted - 4 days ago

https://www.intratio.com/stock-forecast/ONVO ORGANOVO HOLDINGS, INC. The automated equity analyst concludes this company s value will depreciate in the short-term and will continue to have a very poor trend over the next months $ONVO

StockWatch1215 Posted - 4 days ago

$ONVO Do you think this will go back up next week?

OkIGotIt Posted - 5 days ago

$ONVO so tiny float..only 8M..if volume increases even in a few million, it is easy $2. Friday is not the day, but it is a buying day for next week! So much buying lately...

OkIGotIt Posted - 5 days ago

$ONVO This is the 2nd News within a month! Accumulate and wait until they present it to audience! $2 bullish!

OkIGotIt Posted - 5 days ago

$ONVO When they are presenting phase 2's positive results that they scheduled. It will go $2. Within a month two big achievements on drugs! Well done! I loaded when it hit $1. Bullish !